Company Search:
Advanced Search
Sponsored Links
GlaxoSmithKline Pakistan Limited Company Snapshot
GlaxoSmithKline Pakistan Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline Pakistan Limited with three other companies in this sector in Pakistan: Abbott Laboratories (Pakistan) Ltd (2017 sales of 26.09 billion Pakistan Rupees [US$186.53 million] of which 75% was Pharmaceutical), Sanofi Aventis Pakistan Ltd (12.45 billion Pakistan Rupees [US$88.99 million] of which 100% was Pharmaceuticals), and Searle Co Ltd (13.31 billion Pakistan Rupees [US$95.16 million] of which 87% was Pharmaceutical).

Sales Analysis. During the year ended December of 2017, sales at GlaxoSmithKline Pakistan Limited were 32.77 billion Pakistan Rupees (US$234.33 million). This is an increase of 18.9% versus 2016, when the company's sales were 27.56 billion Pakistan Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
GlaxoSmithKline Pakistan Limited
  Stock Performance Chart for GlaxoSmithKline Pakistan Limited
  Stock Data: Recent Stock Performance:
  Current Price (12/14/2018): 116.92
(Figures in Pakistan Rupees)
1 Week -4.0%   13 Weeks -18.1%  
4 Weeks -25.3%   52 Weeks -27.7%  
GlaxoSmithKline Pakistan Limited Key Data:
  Ticker: GLAXO Country: Pakistan
  Exchanges: KAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 32,773,770,000
(Year Ending Jan 2018).
Employees: 2,119
  Currency: Pakistan Rupees Market Cap: 37,235,194,144
  Fiscal Yr Ends: December Shares Outstanding: 318,467,278
  Share Type: Ordinary Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.